Executive Summary: The global Iodine Deficiency Drug Market was valued at USD 1.95 billion in 2024 and is expected to reach USD 3.42 billion by 2032. During the forecast period of 2025 to 2032, the market is likely to grow at a CAGR of 7.1%, primarily driven by the growing awareness of thyroid-related disorders and rising demand for iodine supplementation in developing regions. Th... https://www.databridgemarketresearch.com/reports/global-iodine-deficiency-drug-market